Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv
Item 2 of 2 The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, February 4, 2026. REUTERS/Tom Little/File Photo
[2/2] The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, February 4, 2026. REUTERS/Tom Little/File Photo Purchase Licensing Rights, opens new tab
-
Companies
Follow
Follow
Follow
Show more companies
LONDON, July 21 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Tuesday it was suing rival Eli Lilly (LLY.N), opens new tab in U.S. federal court, accusing the U.S. drugmaker of false advertising in claiming its weight-loss medicines outperform Novo's drugs.
The Danish company said it filed the lawsuit in U.S. District Court in New Jersey, alleging Lilly violated federal and state false advertising and unfair competition laws, including the Lanham Act, through nationwide advertising campaigns for obesity drug Zepbound and diabetes treatment Mounjaro.
The Reuters Daily Briefing newsletter provides all the news you need to start your day. Sign up here.
Novo alleges Lilly compared the highest approved doses of its medicines with lower doses of Novo's Wegovy and Ozempic while omitting newer, higher-dose versions that Novo says deliver greater weight loss.
Novo said it is seeking a court order requiring Lilly to withdraw the advertisements and run a corrective advertising campaign. It added that it plans to seek a preliminary injunction if Lilly does not voluntarily remove the ads.
Novo said it sent Lilly a cease-and-desist letter in April after the U.S. approved a 7.2-milligram dose of Wegovy. Lilly did not respond to the letter, Novo's general counsel John Kuckelman told Reuters, adding that the company instead inserted what he described as an inadequate disclaimer into the advertisements.
Kuckelman said Lilly's advertisements compare weight-loss results of about 50 pounds for Zepbound with about 33 pounds for Wegovy, even though no head-to-head trial has compared the highest approved doses of the medicines. He said separate late-stage trials of the highest doses showed average weight loss of about 48 pounds for Zepbound and 47 pounds for Wegovy.
Reporting by Maggie Fick and Michael Erman; editing by Caroline Humer and Nia Williams
Our Standards: The Thomson Reuters Trust Principles., opens new tab
-
X
-
Facebook
-
Linkedin
-
Email
-
Link
Thomson Reuters
Maggie is a Britain-based reporter covering the European pharmaceuticals industry with a global perspective. In 2023, Maggie's coverage of Danish drugmaker Novo Nordisk and its race to increase production of its new weight-loss drug helped the Health & Pharma team win a Reuters Journalists of the Year award in the Beat Coverage of the Year category. Since November 2023, she has also been participating in Reuters coverage related to the Israel-Hamas war. Previously based in Nairobi and Cairo for Reuters and in Lagos for the Financial Times, Maggie got her start in journalism in 2010 as a freelancer for The Associated Press in South Sudan.
Read Next
- 3 hours agoWorldcategory
In Gaza, a mother's hunt for water lays bare a worsening health crisis
- 29 mins agoEnvironmentcategory
French lawmakers back farm bill despite pesticide outcry
- 10 hours agoHealthcare & Pharmaceuticalscategory
Sri Lanka uses air force drones to tackle spreading dengue outbreak
- 21 mins agoLegalcategory
What has made the cyclospora behind the US outbreak so challenging to trace?
- 18 mins agoWorldcategory
PolyPid, Azurity sign surgical site infection drug deal
World
Hungary's opposition Fidesz party says prosecutors raided its office
Worldcategory · July 21, 2026 · 7:38 AM EDT · 12 mins ago
Hungary's opposition Fidesz party said in a statement on Facebook on Tuesday that prosecutors raided the office where the party's servers are operated from in order to seize the party's communications system and database.
Worldcategory PolyPid, Azurity sign surgical site infection drug deal
7:31 AM EDT
Worldcategory Woman seriously injured in knife attack during church service in Irish town
7:23 AM EDT
Businesscategory Toronto stock futures tick higher on U.S.-Iran diplomacy hopes
7:10 AM EDT
Read Original at Reuters →